Search Results - "Ikediobi, Ogechi"
-
1
Eosinophilic cellulitis in response to BNT162b2 COVID‐19 vaccination
Published in Pediatric dermatology (01-09-2022)“…A 12‐year‐old boy presented with a 2‐week history of persistent pruritic edematous plaques one day after he received the first dose of the BNT162b2 COVID‐19…”
Get full text
Journal Article -
2
The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions
Published in Human genomics (01-04-2010)“…Over the past decade, the number of pharmacogenetic tests has increased considerably, allowing for the development of our knowledge of their clinical…”
Get full text
Journal Article -
3
Analysis of pharmacogenetic traits in two distinct South African populations
Published in Human genomics (01-05-2011)“…Our knowledge of pharmacogenetic variability in diverse populations is scarce, especially in sub-Saharan Africa. To bridge this gap in knowledge, we…”
Get full text
Journal Article -
4
A pilot study using immunohistochemical staining to characterize dihydropyrimidine dehydrogenase expression in keratinocyte neoplasms
Published in JAAD international (01-06-2023)Get full text
Journal Article -
5
-
6
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set
Published in Molecular cancer therapeutics (01-11-2006)“…The panel of 60 human cancer cell lines (the NCI-60) assembled by the National Cancer Institute for anticancer drug discovery is a widely used resource. The…”
Get full text
Journal Article -
7
Pharmacogenetics in dermatology: a patient-centered update
Published in International journal of dermatology (01-08-2013)“…Background The term pharmacogenetics is used to describe an evolving field that aims to understand the relationship between individual variations in genetic…”
Get full text
Journal Article -
8
The clinical application of UGT1A1pharmacogenetic testing: Gene-environment interactions
Published in Human genomics (01-04-2010)“…Over the past decade, the number of pharmacogenetic tests has increased considerably, allowing for the development of our knowledge of their clinical…”
Get full text
Journal Article -
9
In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation
Published in Molecular cancer therapeutics (01-06-2008)“…The panel of 60 human cancer cell lines (the NCI-60) assembled by the National Cancer Institute for anticancer drug discovery is a widely used resource. We…”
Get full text
Journal Article -
10
31783 Etanercept in toxic epidermal necrolysis: In support of standard of care
Published in Journal of the American Academy of Dermatology (01-09-2022)Get full text
Journal Article -
11
Mission Unify: Holistic Admissions Policies Should Include Both African American and Non–African American Blacks
Published in Academic medicine (01-12-2020)Get full text
Journal Article -
12
Pharmacogenomics of Allopurinol and Sulfamethoxazole/Trimethoprim: Case Series and Review of the Literature
Published in Journal of personalized medicine (26-01-2021)“…Severe cutaneous adverse drug reactions (SCAR) such as the Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug rash with eosinophilia and…”
Get full text
Journal Article -
13
New Skin-Colored Nodule in a Patient with Cushing’s Disease: Melanocytic Schwannoma
Published in Skin (Milwood, N.Y.) (17-01-2022)Get full text
Journal Article -
14
CYP2B66 and CYP2B618 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African Women
Published in AIDS research and human retroviruses (01-06-2016)“…Long-term exposure to efavirenz (EFV) measured in hair samples may predict response to antiretroviral treatment (ART). Polymorphisms in CYP2B6 are known to…”
Get more information
Journal Article -
15
Familial secondary hyperhidrosis associated with tumor necrosis factor–alpha inhibitor treatment
Published in JAAD Case Reports (01-11-2015)Get full text
Journal Article -
16
Addressing the Challenges of the Clinical Application of Pharmacogenetic Testing
Published in Clinical pharmacology and therapeutics (01-07-2009)“…Pharmacogenomics aims to use molecular genetic markers to predict treatment outcome. Indeed, within the past decade there has been a rapid emergence of…”
Get full text
Journal Article -
17
Multifactorial regulation of E-cadherin expression: an integrative study
Published in Molecular cancer therapeutics (01-01-2010)“…E-cadherin (E-cad) is an adhesion molecule associated with tumor invasion and metastasis. Its down-regulation is associated with poor prognosis for many…”
Get full text
Journal Article -
18
Pharmacogenomic Applications in Oncology
Published in Journal of pharmacy practice (01-08-2012)“…Oncology chemotherapeutics frequently exhibit a narrow therapeutic index, further complicated by the serious nature of dosing either too high (dangerous…”
Get full text
Journal Article -
19
Long-circulating monensin nanoparticles for the potentiation of immunotoxin and anticancer drugs
Published in Journal of pharmacy and pharmacology (01-05-2001)“…The carboxylic ionophore monensin was formulated into long‐circulating nanoparticles with the help of polyethylene glycol/poly (dl‐lactide‐co‐glycolide)…”
Get full text
Journal Article -
20
Familial secondary hyperhidrosis associated with tumor necrosis factor-alpha inhibitor treatment
Published in JAAD case reports (01-11-2015)Get full text
Report